This article has been updated

Abstract

Concomitant activation of the Wnt pathway and suppression of Mapk signalling by two small molecule inhibitors (2i) in the presence of leukaemia inhibitory factor (LIF) (hereafter termed 2i/L) induces a naive state in mouse embryonic stem (ES) cells that resembles the inner cell mass (ICM) of the pre-implantation embryo1. Since the ICM exists only transiently in vivo, it remains unclear how sustained propagation of naive ES cells in vitro affects their stability and functionality. Here we show that prolonged culture of male mouse ES cells in 2i/L results in irreversible epigenetic and genomic changes that impair their developmental potential. Furthermore, we find that female ES cells cultured in conventional serum plus LIF medium phenocopy male ES cells cultured in 2i/L. Mechanistically, we demonstrate that the inhibition of Mek1/2 is predominantly responsible for these effects, in part through the downregulation of DNA methyltransferases and their cofactors. Finally, we show that replacement of the Mek1/2 inhibitor with a Src inhibitor preserves the epigenetic and genomic integrity as well as the developmental potential of ES cells. Taken together, our data suggest that, although short-term suppression of Mek1/2 in ES cells helps to maintain an ICM-like epigenetic state, prolonged suppression results in irreversible changes that compromise their developmental potential.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Change history

  • 09 August 2017

    The name of the PKC inhibitor in the main text and Methods was corrected.

Accessions

Primary accessions

Sequence Read Archive

References

  1. 1.

    et al. The ground state of embryonic stem cell self-renewal. Nature 453, 519–523 (2008)

  2. 2.

    , , & β-catenin is vital for the integrity of mouse embryonic stem cells. PLoS One 9, e86691 (2014)

  3. 3.

    et al. Erk signaling is indispensable for genomic stability and self-renewal of mouse embryonic stem cells. Proc. Natl Acad. Sci. USA 112, E5936–E5943 (2015)

  4. 4.

    , , , & DNA hypomethylation leads to elevated mutation rates. Nature 395, 89–93 (1998)

  5. 5.

    et al. Induction of tumors in mice by genomic hypomethylation. Science 300, 489–492 (2003)

  6. 6.

    et al. Whole-genome bisulfite sequencing of two distinct interconvertible DNA methylomes of mouse embryonic stem cells. Cell Stem Cell 13, 360–369 (2013)

  7. 7.

    et al. FGF signaling inhibition in ES cells drives rapid genome-wide demethylation to the epigenetic ground state of pluripotency. Cell Stem Cell 13, 351–359 (2013)

  8. 8.

    et al. Naive pluripotency is associated with global DNA hypomethylation. Nat. Struct. Mol. Biol. 20, 311–316 (2013)

  9. 9.

    et al. The two active X chromosomes in female ES cells block exit from the pluripotent state by modulating the ES cell signaling network. Cell Stem Cell 14, 203–216 (2014)

  10. 10.

    et al. Global hypomethylation of the genome in XX embryonic stem cells. Nat. Genet. 37, 1274–1279 (2005)

  11. 11.

    et al. DUSP9 modulates DNA hypomethylation in female mouse pluripotent stem cells. Cell Stem Cell 20, 706–719.e7 (2017)

  12. 12.

    et al. Synergistic mechanisms of DNA demethylation during transition to ground-state pluripotency. Stem Cell Rep. 1, 518–531 (2013)

  13. 13.

    et al. Histone variant H2A.X deposition pattern serves as a functional epigenetic mark for distinguishing the developmental potentials of iPSCs. Cell Stem Cell 15, 281–294 (2014)

  14. 14.

    et al. The transcriptional and epigenomic foundations of ground state pluripotency. Cell 149, 590–604 (2012)

  15. 15.

    & Genomic imprinting in development, growth, behavior and stem cells. Development 141, 1805–1813 (2014)

  16. 16.

    , , , & Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl Acad. Sci. USA 90, 8424–8428 (1993)

  17. 17.

    et al. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 114, 371–383 (2003)

  18. 18.

    et al. Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Nat. Cell Biol. 13, 838–845 (2011)

  19. 19.

    , & A comparative study of protocols for mouse embryonic stem cell culturing. PLoS One 8, e81156 (2013)

  20. 20.

    et al. Impairment of DNA methylation maintenance is the main cause of global demethylation in naive embryonic stem cells. Mol. Cell 62, 848–861 (2016)

  21. 21.

    et al. Self-renewal versus lineage commitment of embryonic stem cells: protein kinase C signaling shifts the balance. Stem Cells 29, 618–628 (2011)

  22. 22.

    et al. Dual inhibition of Src and GSK3 maintains mouse embryonic stem cells, whose differentiation is mechanically regulated by Src signaling. Stem Cells 30, 1394–1404 (2012)

  23. 23.

    et al. Single cell RNA-sequencing of pluripotent states unlocks modular transcriptional variation. Cell Stem Cell 17, 471–485 (2015)

  24. 24.

    et al. Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Cell Stem Cell 15, 471–487 (2014)

  25. 25.

    et al. Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell 158, 1254–1269 (2014)

  26. 26.

    et al. Naive human pluripotent cells feature a methylation landscape devoid of blastocyst or germline memory. Cell Stem Cell 18, 323–329 (2016)

  27. 27.

    ., . & Derivation and long-term propagation of mouse embryonic stem cells. Protoc. Exch. (2017)

  28. 28.

    , , & A reprogrammable mouse strain from gene-targeted embryonic stem cells. Nat. Methods 7, 53–55 (2010)

  29. 29.

    et al. Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature 429, 900–903 (2004)

  30. 30.

    et al. Inactivation of Dnmt3b in mouse embryonic fibroblasts results in DNA hypomethylation, chromosomal instability, and spontaneous immortalization. J. Biol. Chem. 280, 17986–17991 (2005)

  31. 31.

    et al. Gel-free multiplexed reduced representation bisulfite sequencing for large-scale DNA methylation profiling. Genome Biol. 13, R92 (2012)

  32. 32.

    et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454, 766–770 (2008)

  33. 33.

    , & HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169 (2015)

  34. 34.

    et al. Count-based differential expression analysis of RNA sequencing data using R and Bioconductor. Nat. Protocols 8, 1765–1786 (2013)

  35. 35.

    . et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).

  36. 36.

    , & edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010)

  37. 37.

    et al. Mouse genomic variation and its effect on phenotypes and gene regulation. Nature 477, 289–294 (2011)

  38. 38.

    , , , & Sambamba: fast processing of NGS alignment formats. Bioinformatics 31, 2032–2034 (2015)

  39. 39.

    et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009)

  40. 40.

    et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24–26 (2011)

  41. 41.

    et al. Next generation sequencing-based comprehensive chromosome screening in mouse polar bodies, oocytes, and embryos. Biol. Reprod. 94, 76 (2016)

  42. 42.

    et al. WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity. Nature 457, 57–62 (2009)

  43. 43.

    , , & Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009)

  44. 44.

    & Identifying dispersed epigenomic domains from ChIP-Seq data. Bioinformatics 27, 870–871 (2011)

  45. 45.

    et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495–501 (2010)

  46. 46.

    et al. Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc. Natl Acad. Sci. USA 98, 6209–6214 (2001)

  47. 47.

    et al. A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143, 1174–1189 (2010)

  48. 48.

    , & An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5, 976–989 (1994)

  49. 49.

    & Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207–214 (2007)

Download references

Acknowledgements

We thank members of the Hochedlinger laboratory for suggestions as well as L. Barrett for critical reading of the manuscript. Additionally, we thank A. Galvin, M. Gesner and M. Handley at the Massachusetts General Hospital flow cytometry core. We also thank A. L. Hawkins, S. Wang, A. Aggarwal and C. C. Morton at Brigham and Woman’s Hospital CytoGenomics Core Laboratory for karyotyping analysis. We are grateful to K. Shioda from the Shioda laboratory for technical support for genome sequencing. We are also grateful to W. Yu at The Sidney Kimmel Cancer Center Microarray Core Facility at Johns Hopkins University for aCGH analysis, who was supported by NIH grant P30 CA006973 entitled Regional Oncology Research Center. We thank T. Theunissen and R. Jaenisch for sharing human OCT4–eGFP ES cell lines and T. Graf for providing the Rex1–GFP ES cells. A.J.H. is supported by an American Cancer Society–New England Division–Ellison Foundation Postdoctoral Fellowship (PF-15-130-01-DDC). B.D.S. is supported by an EMBO long-term Fellowship (ALTF 1143-2015). T.S. is supported by NIH grant R21ES024861. A.Me. is a New York Stem Cell Foundation Robertson Investigator and supported by NIH grant 1P50HG006193 and the New York Stem Cell Foundation. K.H. was supported by funds from the MGH, HHMI, NIH (R01 HD058013-06) and the Gerald and Darlene Jordan Chair in Regenerative Medicine.

Author information

Author notes

    • Jiho Choi
    •  & Aaron J. Huebner

    These authors contributed equally to this work.

Affiliations

  1. Massachusetts General Hospital Department of Molecular Biology, Boston, Massachusetts 02114, USA

    • Jiho Choi
    • , Aaron J. Huebner
    • , Ryan M. Walsh
    • , Andrej Savol
    • , Bruno Di Stefano
    • , Justin Brumbaugh
    • , Ruslan I. Sadreyev
    •  & Konrad Hochedlinger
  2. Massachusetts General Hospital Cancer Center and Center for Regenerative Medicine, Boston, Massachusetts 02114, USA

    • Jiho Choi
    • , Aaron J. Huebner
    • , Ryan M. Walsh
    • , Bruno Di Stefano
    • , Justin Brumbaugh
    • , Junko Odajima
    • , Toshi Shioda
    •  & Konrad Hochedlinger
  3. Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts 02138, USA

    • Jiho Choi
    • , Aaron J. Huebner
    • , Kendell Clement
    • , Ryan M. Walsh
    • , Bruno Di Stefano
    • , Justin Brumbaugh
    • , Alexander Meissner
    •  & Konrad Hochedlinger
  4. Harvard Stem Cell Institute, 1350 Massachusetts Avenue, Cambridge, Massachusetts 02138, USA

    • Jiho Choi
    • , Aaron J. Huebner
    • , Kendell Clement
    • , Ryan M. Walsh
    • , Bruno Di Stefano
    • , Justin Brumbaugh
    • , Alexander Meissner
    •  & Konrad Hochedlinger
  5. Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA

    • Kendell Clement
    • , Hongcang Gu
    • , Arman Mohammad
    • , Andreas Gnirke
    •  & Alexander Meissner
  6. Department of Genetics, Yale University School of Medicine, 10 Amistad Street, New Haven, Connecticut 06519, USA

    • Kaixuan Lin
    •  & Andrew Xiao
  7. New York University Langone Medical Center, New York 10016, USA

    • Sang-Yong Kim
  8. Center for Integrative Medical Sciences, RIKEN National Research and Development Agency, 1-7-22 Suehiuro-cho, Tsurumi-ku, Yokohama-shi, Kanagawa-ken 230-0045, Japan

    • Jafar Sharif
    •  & Haruhiko Koseki
  9. Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, Massachusetts 02115, USA

    • Christopher M. Rose
    •  & Steven Gygi
  10. Centre de recherche sur le cancer de l’Université Laval, CRCHU de Québec, L’Hôtel-Dieu de Québec, 9, rue McMahon, Quebec G1R 2J6, Canada

    • Jean Charron

Authors

  1. Search for Jiho Choi in:

  2. Search for Aaron J. Huebner in:

  3. Search for Kendell Clement in:

  4. Search for Ryan M. Walsh in:

  5. Search for Andrej Savol in:

  6. Search for Kaixuan Lin in:

  7. Search for Hongcang Gu in:

  8. Search for Bruno Di Stefano in:

  9. Search for Justin Brumbaugh in:

  10. Search for Sang-Yong Kim in:

  11. Search for Jafar Sharif in:

  12. Search for Christopher M. Rose in:

  13. Search for Arman Mohammad in:

  14. Search for Junko Odajima in:

  15. Search for Jean Charron in:

  16. Search for Toshi Shioda in:

  17. Search for Andreas Gnirke in:

  18. Search for Steven Gygi in:

  19. Search for Haruhiko Koseki in:

  20. Search for Ruslan I. Sadreyev in:

  21. Search for Andrew Xiao in:

  22. Search for Alexander Meissner in:

  23. Search for Konrad Hochedlinger in:

Contributions

J. Choi and A.J.H. performed the bulk of the cell culture, teratoma assays, dot blot and flow cytometry analyses; J. Choi, A.J.H. and S.-Y.K. performed the blastocyst injections; J. Choi, A.J.H. and J. Charron generated the Mek1/2 double-knockout iPS cell lines; R.M.W. generated the XGXT ES cell line; J.S. and H.K. generated the Dnmt triple-knockout ES cell line; J. Choi, A.J.H. and J.B. conducted the western blot analysis; J.B., C.M.R. and S.G. performed the proteomics analysis; B.D.S. performed experiments related to human ES cell culture; J.O. and T.S. performed the genome sequencing analyses and analysed the RNA-seq data of interspecies iPS cell lines; K.C., H.G., A.Mo., A.G. and A.Me. performed the RRBS analyses; A.S. and R.I.S. performed the RNA-seq analyses; K.L. and A.X. conducted the H2A.X ChIP–seq analysis.; J. Choi, A.J.H. and K.H. designed the experiments, interpreted the results and wrote the manuscript.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Konrad Hochedlinger.

Reviewer Information Nature thanks T. Zwaka and the other anonymous reviewer(s) for their contribution to the peer review of this work.

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data

Supplementary information

PDF files

  1. 1.

    Supplementary Figure

    This file contains the uncropped western blots corresponding to the labelled figures.

Excel files

  1. 1.

    Supplementary Tables

    This file contains Supplementary Tables 1-3.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nature23274

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing